Opus Genetics

RESEARCH TRIANGLE PARK, N.C., May 7, 2026 Opus Genetics announced new clinical and preclinical data presentations at the 2026...

RESEARCH TRIANGLE PARK, N.C. – May 4, 2026 Opus Genetics Inc. has announced that its investigational gene therapy OPGx-LCA5...

Research Triangle Park, N.C. | January 27, 2026 — Opus Genetics, Inc., a clinical-stage biopharmaceutical company focused on inherited...